Dr Albert Edwards

Urologist

Men's Health

Sub-specialties: Men's Health, Urology, Prostate, Urological Cancer, Prostate Cancer.

Overview
Consultant Profile Image

bookings.menshealth@onewelbeck.com

02036532042

Overview

Dr Albert Edwards is a Consultant Clinical Oncologist specialising in prostate cancer and a member of OneWelbeck’s Urological Cancer Specialist Multidisciplinary Team. He offers Proton Beam Therapy, MR-Linac radiotherapy, SABR, IMRT, and prostate brachytherapy (HDR and LDR). He is an expert in inserting SpaceOAR Hydrogel spacers for prostate radiotherapy patients.

About Dr Albert Edwards

Dr Albert Edwards is a Consultant Clinical Oncologist at OneWelbeck Men's Health.

He specialises in treating prostate cancer with advanced radiotherapy techniques and brachytherapy, and inserting SpaceOAR Hydrogel into patients planned for prostate radiotherapy. 

He offers Proton Beam Therapy at University College London Hospital to UK and international patients. He treats prostate cancer on MR-Linac and offers SABR and IMRT on conventional radiotherapy machines.

Areas of Expertise

Dr Albert Edwards performs a range of treatments including:

  • SpaceOAR insertion
  • Proton Beam Therapy
  • Radiotherapy
  • Prostate LDR Brachytherapy
  • Prostate HDR Brachytherapy
  • MRI-Linac SABR
  • Prostate SABR
  • SBRT

Additional Information

Dr Albert Edwards active memberships:

  • Member of the Royal College of Radiologists
  • British Uro-Oncology Group

Dr Albert Edwards current clinical posts and locations:

  • University College Hospital London
  • Maidstone Hospital, Kent
  • Kent and Canterbury Hospital, Canterbury
  • The Chaucer Hospital, Canterbury

 

Research Highlights

Dr Albert Edwards notable publications:

Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK https://bmjopen.bmj.com/content/12/7/e060506
A. A. Edwards, R. W. Laing, and S. E. M. Langley. Urological Oncology, chapter 43: Brachytherapy for Prostate Cancer, pages 743–772. Springer London, London, 2nd edition, Nov 2015.
A. Edwards, R. Laing, and S. Langley. Favourable long-term outcomes with brachytherapy-based regi- mens in men ≤60 years with clinically localized prostate cancer. BJU Int, 111(8):1181–1182, Jun 2013.

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.